PRESS RELEASE published on 02/06/2025 at 19:30, 1 year 8 months ago Informations privilégiées / Autres communiqués La BEI lève deux clauses financières du contrat de prêt avec Medincell. 40 millions d'euros accordés en 2022 remplacent un prêt de 20 millions. Tranches A, B, C tirées en 2022-2023, première maturité en 2027. Deux clauses financières seront levées Medincell Maturité BEI Prêt Clauses Financières
BRIEF published on 01/29/2025 at 15:47, 1 year 9 months ago UZEDY® Achieves $117M in Sales in 2024 Teva Pharmaceuticals 2025 Projections UZEDY® Sales Medincell Partnership Olanzapine Injectable
BRIEF published on 01/29/2025 at 15:47, 1 year 9 months ago UZEDY® réalise un chiffre d'affaires de 117 millions de dollars en 2024 Teva Pharmaceuticals Prévisions Pour 2025 Olanzapine Injectable Ventes UZEDY® Partenariat Medincell
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 9 months ago Inside Information / Other news releases UZEDY® sales reach $117M in 2024, surpassing Teva's expectations. Medincell poised for $160M in 2025 with Olanzapine Long-Acting Injectable near launch. Key partnership and financial insights Sales Partnership Medincell Teva Pharmaceuticals UZEDY®
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 9 months ago Informations privilégiées / Autres communiqués Les ventes de UZEDY® par Teva Pharmaceuticals atteignent 117 M$ en 2024, dépassant les prévisions, Medincell perçoit des royalties. Préparation de lancement de l'Olanzapine LAI (TEV-749 / mdc-TJK) Royalties Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY®
BRIEF published on 12/12/2024 at 21:35, 1 year 10 months ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
BRIEF published on 12/12/2024 at 21:35, 1 year 10 months ago Medincell rejoint l'indice Euronext SBF 120 Capitalisation Boursière Visibilité Financière CAC 40 Euronext SBF 120 Médinecell
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 10 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 10 months ago Informations privilégiées / Autres communiqués Medincell intègre l'indice Euronext SBF 120 et CAC Mid 60, renforçant sa visibilité et attractivité pour les investisseurs. Découvrez les déclarations et impacts de cette intégration Euronext Intégration SBF 120 Medincell CAC Mid 60
PRESS RELEASE published on 12/10/2024 at 17:47, 1 year 10 months ago Medincell Rapport Financier semestriel 01-04-24 au 30-09-2024
Published on 10/30/2026 at 23:35, 3 hours 12 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 3 hours 17 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 7 hours 47 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 11 hours 17 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 3 hours 58 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 8 hours 9 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 3 hours 47 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 3 hours 47 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
